myirislogo
04 May, 2015 03:25 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Axis Bank 567.85 2.70
State Bank O 270.05 0.64
Icici Bank 331.25 0.33
Hindalco In 129.05 1.11
Sun Pharma 939.40 0.02
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Claris Lifesciences Limited
Claris Lifesciences Limited
Sector:Pharmaceuticals Pharmaceuticals - Pharmaceuticals - Others
BSE:533288NSE:NABloomberg:CLAR@INReuters:CLAI.BO
Market Lot: 1Face Value: 10ISIN Demat: INE562G01018
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
20-APR-15 Claris Lifesciences, one of the largest sterile injectables pharmaceutical companies in India, has reached a settlement and license agreement, ending all pending litigation with Fresenius Kabi USA, Inc. With reference to the alleged infringement of a patent relating to Propofol for injection, 10mg/ml, which is a generic version of DIPRIVAN. 20-MAR-15 India Ratings & Research (Ind-Ra) has affirmed Claris Lifesciences (CLL) long-term i...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Claris Lifesciences surges on settlement with Fresenius Kabi USA  -IRIS 20-Apr-15
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2014(12)31-Dec-2013 (12)31-Dec-2012(12)
Net sales 5925.716287.947140.72
Other Income680.74404.95147.73
Total Income6606.456692.897288.45
Cost of goods sold4824.564804.654927.97
OPBDIT1781.891888.242360.48
PAT1414.68812.19744.17
Gross Block---
Equity capital545.68638.18638.18
EPS (Rs.)-12.73-
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-11.16 - 18.22-
Debt / Equity (x)---
Operating margin (% of OI)27.028.232.4
Net margin (% of OI)21.412.110.2
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Claris Corporate Headquarters
Near Parimal Railway Crossing
Ellisbridge
Ahmedabad
Gujarat-380 006
PHONE
(079) 2656 3331/ 6630 9330
FAX
(079) 2656 5879/ 2640 8053
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer